tiprankstipranks
Advertisement
Advertisement

INVA Stock Latest News

3 Small-Cap ‘Strong Buy’ Stocks with Big Upside in 2026, According to Analysts
Market News3 Small-Cap ‘Strong Buy’ Stocks with Big Upside in 2026, According to Analysts
26d ago
DEC
ATRC
Innoviva price target raised to $32 from $31 at Cantor Fitzgerald
PremiumThe Fly
Innoviva price target raised to $32 from $31 at Cantor Fitzgerald
1M ago
INVA
Innoviva reports Q4 EPS $1.94 vs. 26c last year
PremiumThe Fly
Innoviva reports Q4 EPS $1.94 vs. 26c last year
1M ago
INVA
Innoviva initiated with a Buy at BTIG
PremiumThe Fly
Innoviva initiated with a Buy at BTIG
1M ago
INVA
Innoviva: Durable Royalty Backbone and High-Growth Hospital Portfolio Underpin Buy Rating and $35 Target
PremiumRatings
Innoviva: Durable Royalty Backbone and High-Growth Hospital Portfolio Underpin Buy Rating and $35 Target
1M ago
INVA
Innoviva price target raised to $46 from $45 at H.C. Wainwright
PremiumThe FlyInnoviva price target raised to $46 from $45 at H.C. Wainwright
3M ago
INVA
Innoviva Specialty Therapeutics announces FDA approval of Nuzolvence
Premium
The Fly
Innoviva Specialty Therapeutics announces FDA approval of Nuzolvence
4M ago
INVA
Innoviva’s Zoliflodacin: A Promising Antibiotic Driving Buy Rating Amidst Urgent Need for Drug-Resistant Infection Solutions
Premium
Ratings
Innoviva’s Zoliflodacin: A Promising Antibiotic Driving Buy Rating Amidst Urgent Need for Drug-Resistant Infection Solutions
4M ago
INVA
Innoviva announces Lancet publication of ‘positive’ Zoliflodacin Phase 3 data
PremiumThe Fly
Innoviva announces Lancet publication of ‘positive’ Zoliflodacin Phase 3 data
4M ago
INVA
Roth Capital healthcare analyst holds an analyst/industry conference call
PremiumThe Fly
Roth Capital healthcare analyst holds an analyst/industry conference call
4M ago
BDX
JNJ
Innoviva Reports Strong Q3 2025 Financial Results
PremiumCompany Announcements
Innoviva Reports Strong Q3 2025 Financial Results
5M ago
INVA
Innoviva management to meet virtually with Oppenheimer
PremiumThe Fly
Innoviva management to meet virtually with Oppenheimer
5M ago
INVA
Innoviva’s Strong Q3 2025 Performance and Growth Prospects Drive Buy Rating
PremiumRatingsInnoviva’s Strong Q3 2025 Performance and Growth Prospects Drive Buy Rating
5M ago
INVA
Innoviva reports Q3 EPS $1.08 vs. 2c last year
Premium
The Fly
Innoviva reports Q3 EPS $1.08 vs. 2c last year
5M ago
INVA
Innoviva board authorizes $125M share repurchase program
Premium
The Fly
Innoviva board authorizes $125M share repurchase program
5M ago
INVA
Innoviva (INVA) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Innoviva (INVA) Q3 Earnings Cheat Sheet
5M ago
INVA
Innoviva’s Future Challenges: Sell Rating Amid Patent Cliff and Revenue Pressures
PremiumRatings
Innoviva’s Future Challenges: Sell Rating Amid Patent Cliff and Revenue Pressures
6M ago
INVA
Innoviva initiated with a Sell at Goldman Sachs
PremiumThe Fly
Innoviva initiated with a Sell at Goldman Sachs
6M ago
INVA
Arm initiated, Adobe downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Arm initiated, Adobe downgraded: Wall Street’s top analyst calls
8M ago
UE
ARM
Innoviva initiated with an Outperform at Oppenheimer
PremiumThe FlyInnoviva initiated with an Outperform at Oppenheimer
8M ago
INVA
Innoviva price target raised to $45 from $40 at H.C. Wainwright
Premium
The Fly
Innoviva price target raised to $45 from $40 at H.C. Wainwright
8M ago
INVA
Innoviva Reports Strong Q2 2025 Financial Results
Premium
Company Announcements
Innoviva Reports Strong Q2 2025 Financial Results
8M ago
INVA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >